Elexacaftor / Ivacaftor / Tezacaftor ( DrugBank: Ivacaftor, Tezacaftor, Elexacaftor )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
299	Cystic fibrosis	2

299. Cystic fibrosis

---

Clinical trials : 1,695 /  Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05699148 (ClinicalTrials.gov)	April 1, 2022	10/1/2023	Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior	Gut Imaging for Function and Transit in Cystic Fibrosis 3 Junior: an Evaluation of Triple Combination Therapy in Children Aged 6 to 11 Years	Cystic Fibrosis	Drug: Elexacaftor / Ivacaftor / Tezacaftor	Nottingham University Hospitals NHS Trust	NULL	Active, not recruiting	6 Years	11 Years	All	17		United Kingdom
2	NCT05576324 (ClinicalTrials.gov)	December 30, 2020	27/9/2022	Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - Ivacaftor	Effect of the CFTR-modulating Triple Therapy Elexacaftor - Tezacaftor - Ivacaftor on Numerical Distribution in Peripheral Mononuclear Immune Cells Derived From Patients With Cystic Fibrosis	Cystic Fibrosis	Drug: Elexacaftor / Ivacaftor / Tezacaftor	University of Erlangen-Nürnberg Medical School	NULL	Recruiting	6 Years	N/A	All	130		Germany